Biomedica
- Company typePrivate
- Founded1991
- HeadquartersPraha, Czechia
- Headcount251–500
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
Biomedica firmographics
Firmographics- Name
- Biomedica
- Legal name
- Biomedica, spol. s r.o.
- Website
- https://bio-medica.eu
- Company type
- Private
- Founded year
- 1991
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Ownership category
- akta.pro rank
Biomedica industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Medical Equipment and Supplies Manufacturing (33911)
- SIC
- Pharmaceutical Preparations (2834), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Pharmaceutical & Medical Device Packaging (GMP, Tamper-Evident, Cold-Chain Packs) (TLAIAGAI)
- akta.pro secondary industry
- OTC Medicines & Consumer Health Products Distribution (CRAOAHAB)
Keywords
Where Biomedica is headquartered
LocationHeadquarters
- HQ city
- Praha
- HQ country
- Czechia
- HQ region
- Europe
Offices5 records
Markets served
Biomedica business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales
Revenue model
- Own Brand Product Sales: Sale of pharmaceutical products, medical devices, food supplements, and cosmetics under the Biomedica brand through pharmacies in Czech Republic, Slovakia, and other markets.
- Contract Manufacturing Services: Development and manufacturing services for pharmaceutical companies and businesses from Czech Republic and other European countries. Services include product development, registration (e-CTD format), production, quality control, and packaging/adjustment.
- Raw Material Sales: Supply of approximately 1,600 raw materials for food supplements, sports nutrition, cosmetics, and household chemicals. Includes essential oils, plant extracts, vitamins, minerals, and other ingredients.
Go-to-market motion2 records
Distribution channels6 records
Marketing channels6 records
Biomedica product offering
Product offeringCore offering
Biomedica manufactures and distributes pharmaceutical products (RX and OTC), medical devices, food supplements, and cosmetics under its own brand, while also providing contract manufacturing, raw material supply (~1,600 items), and product registration services to partner companies across Europe and beyond.
Product overview
Biomedica is a Czech pharmaceutical company founded in 1991 operating as a traditional manufacturer of medicinal products, food supplements, cosmetics, and medical devices. The company operates through three main pillars: production of own branded products (Biomedica brand), contract manufacturing services, and raw material sales. Under the Biomedica brand, the product portfolio includes prescription medicines (RX) such as Framykoin and Kalium Chloratum, over-the-counter medicines (OTC) including Lactulosa and Magnesium Lactate, medical devices consisting of sterile infusion and dialysis solutions (Natrium Citricum series, Citralysat series, Lactocitrate, Prismalysat), food supplements, and cosmetics. The company also operates a comprehensive contract manufacturing division offering development, registration, and production services for pharmaceuticals, medical devices, food supplements, and cosmetics across various dosage forms. Additionally, Biomedica supplies approximately 1600 raw materials including essential oils, vegetable oils, extracts, vitamins, minerals, and other ingredients for the food supplement, cosmetics, and household chemical industries.
Differentiator
Problem solved
Functional benefit
Brands
- Lactocitrate: Infusion solution product line for dialysis treatments
- Citralysat
- Prismalysat
Products and services
- Contract Pharmaceutical Manufacturing End-to-end GMP contract manufacturing of sterile and non-sterile pharmaceutical dosage forms, including development, technology transfer, validation, and commercial supply for partner companies. Targeted at pharmaceutical marketing-authorization holders and brand owners needing outsourced production capacity.
- Pharmaceutical Product Registration Services Regulatory affairs and product registration service supporting pharmaceutical partners in obtaining and maintaining marketing authorizations across EU and select non-EU markets.
- Raw Materials and Consumables Catalogue Distribution of approximately 1,600 pharmacopoeial-grade raw materials, excipients, reagents, and laboratory consumables to laboratories, compounding pharmacies, and small manufacturers.
- Sterile Infusion Solutions (Mediekos range) RX-grade sterile infusion solutions such as Aqua pro injectione Mediekos and Infusio natrii chlorati isotonica Mediekos F1/1, supplied to hospitals, ICUs, and clinical settings for intravenous and irrigation use.
- Dialysis Concentrates (Natrium Citricum, Citralysat, Lactocitrate, Prismalysat series) Medical device line of citrate-based and lactate-based dialysis concentrates (Natrium Citricum, Citralysat, Lactocitrate, Prismalysat) supplied to renal dialysis centers for hemodialysis treatment.
- RX Tablets (Framykoin, Kalium Chloratum Biomedica 500 mg) Prescription-only solid oral dosage products such as Framykoin and Kalium Chloratum Biomedica 500 mg tablets, distributed via pharmacies and hospitals for the relevant therapeutic indications.
- OTC Oral Solutions (Lactulosa, Magnesium Lactate Biomedica) Over-the-counter oral solutions including Lactulosa Biomedica 667 mg/ml and Magnesium Lactate Biomedica 500 mg, sold through pharmacy retail and the company e-shop for self-care use.
- Biomedica Food Supplements Own-brand food supplement range distributed via pharmacies, retail, and the company e-shop for consumer health and wellness.
- Biomedica Cosmetics Own-brand cosmetic products sold through pharmacy retail and online channels.
Quantifiable outcome
- Products distributed in 16 countries worldwide
- +3 more outcomes
Companies that use Biomedica
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles4 records
Biomedica technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Biomedica partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- DUOMEDICA GmbHcoreGerman subsidiary based in Maintal serving as foreign representation for German-speaking markets. Handles sales and distribution of Biomedica products in Germany.
- DELTAMEDICA GmbHcoreGerman subsidiary based in Reutlingen serving as foreign representation for German and broader European markets. Handles sales and distribution of Biomedica products.
Scale indicators7 records
Recent moves5 records
Expansion highlights5 records
Biomedica competitors and assessment
Company assessmentDirect peers
- Walmark: Walmark is a Czech and Slovak consumer health company specializing in OTC, food supplements, and herbal-based products distributed through pharmacies. It is directly comparable to Biomedica's own-brand OTC and supplement portfolio in terms of regional reach, channel (pharmacy + e-commerce), and herbal positioning.
- Glatt Group: Glatt is a German pharmaceutical process technology and CDMO company offering contract manufacturing for solid and semi-solid dosage forms. It is a comparable CMO for the German-speaking market that Biomedica accesses via its German subsidiaries.
- NextPharma: NextPharma is a European CDMO operating multiple manufacturing sites offering solid, semi-solid, and sterile dose forms across Europe. It is a like-for-like comparable for Biomedica's contract manufacturing services serving European pharma clients seeking GMP-certified production.
- Famar: Famar is a European CDMO based in Greece offering sterile, solid dose, and semi-solid contract manufacturing services to pharma and consumer health clients. It competes for the same European CMO contracts that Biomedica targets, with similar service breadth.
- Sopharma: Sopharma is a Bulgarian pharmaceutical manufacturer producing generics, OTC, and herbal-based products with broad CEE distribution. Its herbal-and-natural product focus and CEE regional presence mirror Biomedica's three-pillar model.
- Aenova Group: Aenova is one of Europe's largest contract development and manufacturing organizations (CDMO), headquartered in Germany, offering solid, semi-solid, sterile, and consumer health manufacturing. It is a direct competitor for Biomedica's CDMO business across the German-speaking markets that Biomedica targets via DUOMEDICA and DELTAMEDICA.
- Vipharm: Vipharm is a Polish pharmaceutical manufacturer offering contract manufacturing and Rx/OTC products across CEE. With similar size and Central European footprint to Biomedica, it competes for regional CMO contracts and pharmacy distribution deals.
- Dr. Müller Pharma: Dr. Müller Pharma is a Czech OTC and food supplement manufacturer with similar mid-size scale and herbal/natural positioning to Biomedica. It competes directly for Czech and Slovak pharmacy shelf space and consumer health contracts.
- Zentiva: Headquartered in Prague, Zentiva is the largest Czech pharmaceutical manufacturer with significant CMO services and an OTC/generics portfolio. It competes directly with Biomedica across all three pillars in the Czech and broader CEE market, including contract manufacturing and pharmacy distribution.
Broad incumbents
- Catalent: Catalent is a global CDMO with extensive pharmaceutical contract manufacturing services across multiple dosage forms and geographies. While much larger, it competes with Biomedica for European pharma client contracts in softgel, oral solid, and sterile formats where Biomedica participates.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Biomedica social profiles
Digital presenceBiomedica financial estimates
Financial estimateRevenue estimate
Valuation estimate
Biomedica leadership team
Management profileNumber of profiles
Profiles6 records
Biomedica subsidiaries and ownership
Company hierarchySubsidiaries2 records
Biomedica funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Biomedica M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Biomedica
What does Biomedica do?
Biomedica manufactures and distributes pharmaceutical products (RX and OTC), medical devices, food supplements, and cosmetics under its own brand, while also providing contract manufacturing, raw material supply (~1,600 items), and product registration services to partner companies across Europe and beyond.
Is Biomedica a public or private company?
Biomedica is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Biomedica founded?
Biomedica was founded in 1991. It employs 251 to 500 people.
Where is Biomedica based?
Biomedica is headquartered in Praha, Czechia, in the Europe region.
How does Biomedica make money?
Three revenue lines are on record. Own Brand Product Sales are the primary driver. The others are contract Manufacturing Services and raw Material Sales.
Who are Biomedica's main competitors?
Direct peers on record are Walmark, Glatt Group, NextPharma, Famar, Sopharma, Aenova Group, Vipharm, Dr. Müller Pharma and Zentiva. Catalent is listed as a broad incumbent.
Does Biomedica have an API?
No public API is recorded for Biomedica.
What industry is Biomedica in?
Biomedica's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is TLAIAGAI, Pharmaceutical & Medical Device Packaging (GMP, Tamper-Evident, Cold-Chain Packs), with a secondary code of CRAOAHAB, OTC Medicines & Consumer Health Products Distribution. Its NAICS code is 325412 and its SIC code is 2834.